Pharmaceutical Insights: Weight Loss Drug Spending and Medicine Launch Prices
Explore the latest updates on spending for weight loss drugs and the launch prices of new medications in the pharmaceutical sector.
Latest Medicine stories from Life.
Explore the latest updates on spending for weight loss drugs and the launch prices of new medications in the pharmaceutical sector.
The Department of Homeland Security has reported on recent arrests made by ICE, targeting individuals involved in serious crimes such as sexual predation, drunk driving, and drug trafficking.
Bode Miller, a celebrated figure in American Alpine skiing, has been arrested on two drug charges in Idaho earlier this month, raising concerns about his well-being.
New guidance from CMS outlines the medical frailty exemption from Medicaid work requirements, highlighting potential challenges for states in implementation.
Home Minister Ramesh Chennithala asserts that drug laws will be applied equally to all individuals, including VIPs, amid concerns about drug use at high-profile events.
In a notable case, Eli Lilly and the FDA have provided a 79-year-old patient with access to an experimental obesity drug through the compassionate use program, highlighting ethical considerations in drug access.
The process of developing new medications often involves extensive chemistry experiments to find the optimal formulation for a drug that is safe, effective, and affordable.
Pfizer's latest experimental drug, intended to replace conventional chemotherapy for lung cancer, has not achieved the desired results in clinical trials.
In a significant move for the pharmaceutical industry, AbbVie has announced its acquisition of Apogee for $10.9 billion, marking its largest deal in over five years amid a wave of mergers and acquisitions.
In a notable move within the biotech sector, AbbVie has completed the acquisition of Apogee Therapeutics, reflecting a renewed interest in mergers and acquisitions in the industry.
In this edition of Pharmalittle, we explore recent developments including an FDA reversal and ongoing mergers and acquisitions in the pharmaceutical industry.
Definium Therapeutics has reported encouraging results from its Phase 3 trial of LSD therapy for major depression, signaling a step toward possible regulatory approval.
In a significant development, the FDA's advisory committee has unanimously recommended the approval of Moderna's mRNA vaccine, despite recent controversies surrounding the agency.
As the head of medical staff for Curacao's national men's football team, Dr. Suzanne Huurman represents the smallest team by population and size in World Cup history.
New research highlights the effects of intermittent fasting on chronic stress, advancements in physics through macroscopic entanglement, and the ongoing mystery of gamma-ray bursts.
Recent developments in nanorobotics highlight the potential of infrared navigation technology, which may improve the efficiency of drug delivery in complex physiological environments.
The recent discovery of H5N1 bird flu in U.S. cattle highlights the disease's atypical presentation, complicating timely diagnosis.
AbbVie is reportedly nearing an $11 billion acquisition of Apogee Therapeutics, reflecting a trend of increased dealmaking in the biotech sector as pharmaceutical companies aim to enhance their drug portfolios.
Pharmacies in Tennessee are reportedly selling strong formulations of ivermectin, a practice spearheaded by a physician known for his anti-vaccine stance.
An FDA advisory panel has endorsed Moderna's seasonal mRNA flu vaccine, which had previously been embroiled in controversy earlier this year.